ALK-ABELLO AS B SHS NEW by Alk Abello AS (AKBLF) Stock Price, Quote, News & History

AKBLFOTCPK

Trade with Public

$35.55

Last update: Apr 21, 11:53 AM

OverviewNews Short Interest

Key Statistics

Open

Volume / Avg.

0 / 565.00

Day Range

- - -

52 Wk Range

25.95 - 36.14

Market Cap

P/E Ratio

39.03

Dividend Yield

0.69%

Exchange

OTC

RSI

Short Interest

Days to Cover

198.33

Recent ALK-Abello A/S News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

2.19B

Investing Cash Flow (TTM)

-416.00M

Financing Cash Flow (TTM)

-731.00M

Free Cash Flow (TTM)

1.80B

Capital Expenditure (TTM)

-393.00M

Net Change in Cash (TTM)

1.04B

Valuation Metrics

Enterprise Value

$8.62B

PE Ratio (TTM)

39.03

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

7.63

PB Ratio (TTM)

7.64

Earnings Yield % (TTM)

2.56%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

26.03

Price / EBITDA (TTM)

23.75

Price / Free Cash Flow (TTM)

27.87

Book Value / Share

$4.66

Company Debt

Total Debt

$164.00M

LT Debt

$147.00M

LT Debt Issuance (TTM)

-$298.00M

LT Debt Repayment (TTM)

-$15.00M

Total Cash

$1.55B

Debt to Equity

0.06

Issuance of Debt (TTM)

-$313.00M

Repayment of Debt (TTM)

-$15.00M

Key Statistics

Open

Volume / Avg.

0 / 565.00

Day Range

- - -

52 Wk Range

25.95 - 36.14

Market Cap

P/E Ratio

39.03

Dividend Yield

0.69%

Exchange

OTC

RSI

Short Interest

Days to Cover

198.33

About

Sector

Health Care

Industry

Pharmaceuticals

Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy ALK-ABELLO AS B SHS NEW by Alk Abello AS (AKBLF) stock?

You can purchase shares of ALK-ABELLO AS B SHS NEW by Alk Abello AS (OTCPK:AKBLF) through any online brokerage.

View our list of the best stock brokerages

Who are ALK-ABELLO AS B SHS NEW by Alk Abello AS (AKBLF) competitors?

There are no as such competitors for ALK-ABELLO AS B SHS NEW by Alk Abello AS.

What is the forecast, or price target, for ALK-ABELLO AS B SHS NEW by Alk Abello AS (AKBLF) stock?

There is no analysis for ALK-ABELLO AS B SHS NEW by Alk Abello AS to provide a consensus price target.

What is the current price for ALK-ABELLO AS B SHS NEW by Alk Abello AS (AKBLF)?

The stock price for ALK-ABELLO AS B SHS NEW by Alk Abello AS (OTCPK: AKBLF) is $35.554 last updated April 21, 2026 at 11:53 AM EDT.

Does ALK-ABELLO AS B SHS NEW by Alk Abello AS (AKBLF) pay a dividend?

There are no upcoming dividends for ALK-ABELLO AS B SHS NEW by Alk Abello AS.

When is ALK-ABELLO AS B SHS NEW by Alk Abello AS (OTCPK:AKBLF) reporting earnings?

ALK-ABELLO AS B SHS NEW by Alk Abello AS does not have any upcoming earnings scheduled.

Is ALK-ABELLO AS B SHS NEW by Alk Abello AS (AKBLF) going to split?

There is no upcoming split for ALK-ABELLO AS B SHS NEW by Alk Abello AS.

What sector and industry does ALK-ABELLO AS B SHS NEW by Alk Abello AS (AKBLF) operate in?

ALK-ABELLO AS B SHS NEW by Alk Abello AS is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.